Citation & Authors
Front Immunol. 2026;17:1745048.
ABSTRACT · CHINESE TRANSLATION
Translated abstract
Translated from the licensed abstract via the Chinese version. This is not an official journal translation.
purpose
To compare real-world skeletal and survival outcomes in patients with rheumatoid arthritis (RA) receiving JAK versus TNF inhibitors.
method
This retrospective cohort study used a collaborative electronic health record network covering 2016–2024. After 1:1 propensity score matching, each group included 16,572 patients, followed for up to 5 years. The primary outcomes were the composite of any fracture or osteoporosis, fracture and osteoporosis separately, and all-cause mortality.
result
In the matched cohort, JAK inhibitors were associated with lower risks of the composite outcome (HR 0.930) and osteoporosis (0.906) than TNF inhibitors, but a reduction in fracture risk was not clearly observed. JAK inhibitors were also associated with higher all-cause mortality (1.582). Subgroup estimates suggested possible heterogeneity, but these findings were exploratory.
Conclusion
In this large electronic health record cohort, initiation of JAK inhibitors was associated with fewer osteoporosis-related outcomes but higher all-cause mortality than initiation of TNF inhibitors. Given the observational design, potential residual confounding, and limited follow-up for most patients, the findings should be interpreted as associations and validated in other datasets and prospective studies.
Reasons for research
To compare real-world skeletal outcomes and all-cause mortality associated with JAK versus TNF inhibitor use in patients with RA.
Main results
In the propensity score-matched cohort, JAK inhibitors were associated with fewer osteoporosis-related outcomes but higher all-cause mortality.
meaning
These observational findings suggest a potential trade-off between benefits and risks, highlighting the need for individualized risk–benefit discussions and validation in other datasets and prospective studies.
Original work: Author of the above paper. Source:Public Summary ↗. This translation is based on the Chinese rendering of the original English abstract.
Original work license:CC BY ↗;Translations are subject to the same licensing conditions.
